(Update) Acalabrutinib in CLL and MCL
Zanubrutinib
Obinutuzumab
Update Venetoclax in CLL
JADPRO Roundtable Series: Best Practices in the Use of BTK Inhibitors in CLL
Cancer.gov
ASCO: COVID-19 Medical Resources
Patient Power